Main competitors
Consensus (Composite) Analysts' target price evolution (4 months) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Average Target P. Ecart obj. / dr Nbr of analysts
€667.35 +37.31% 15
CN¥83.73 +6.25% 18
US$116.43 +20.18% 21
US$25.71 +22.37% 9
US$113.55 +8.57% 18
HK$102.42 -11.14% 20
HK$27.52 +10.59% 26
DKK 1,928.76 +37.13% 16
US$45.89 +2.42% 19
HK$330.26 -7.07% 16
US$106.22 +1.42% 9
US$425 +23.2% 14
US$76.29 +91.92% 19
CN¥99.04 +1.04% 2
₹382.9 -2.98% 20
US$117.3 +37.27% 10
NT$690.5 +30.28% 4
HK$39.92 -36.39% 14
US$125.75 +243.86% 8
Average 289.71 +27.17% 15
Weighted average by Cap. 299.71 +20.83% 16
Bio Therapeutic Drugs